Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $120

Benzinga · 19h ago
Barclays analyst Christopher Pasquale maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $110 to $120.